News & Updates

Treatment with anti-CD20 monoclonal antibodies appears to be a viable option for patients with relapsing-remitting multiple sclerosis (RRMS) who have uncontrolled disease following the use of alemtuzumab therapy, suggests a study presented at EAN 2024.

A diagnosis of irritable bowel syndrome (IBS), a common functional gastrointestinal disorder, appears to contribute to a reduced risk of death, but this association weakens over time, a study has shown.

Diabetic patients with primary open-angle glaucoma (POAG) are at greater risk of developing diabetic retinopathy (DR), reveals a study, noting the need for screening and comprehensive management in glaucomatous patients with diabetes to reduce the risk of DR.

Use of aspirin, although safe, does not appear to provide any meaningful beneficial effects for diabetic retinopathy (DR), a study has shown.